aXichem AB Series A | Balance Sheet

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
16,671.20
4,535.00
6,445.00
497.00
5,743.00
Total Accounts Receivable
206.80
1,254.00
706.00
17,447.00
646.00
Inventories
330.00
190.00
6.00
138.00
90.00
Other Current Assets
-
70.00
-
90.00
-
Total Current Assets
17,208.00
6,049.00
7,157.00
18,172.00
6,479.00
Total Investments and Advances
-
-
-
31.00
31.00
Intangible Assets
16,561.10
19,326.00
23,717.00
28,807.00
32,051.00
Total Assets
33,769.10
25,375.00
30,874.00
47,010.00
38,561.00
ST Debt & Current Portion LT Debt
1,500.00
-
-
-
-
Accounts Payable
2,139.60
738.00
517.00
1,090.00
667.00
Income Tax Payable
-
-
53.00
-
-
Other Current Liabilities
10,566.20
5,703.00
398.00
871.00
298.00
Total Current Liabilities
14,205.90
6,441.00
968.00
1,961.00
965.00
Long-Term Debt
-
-
-
-
3,735.00
Other Liabilities
-
-
3,636.00
3,718.00
-
Total Liabilities
14,205.90
6,441.00
4,604.00
5,679.00
4,700.00
Common Equity (Total)
19,563.20
18,934.00
26,270.00
41,331.00
33,861.00
Total Shareholders' Equity
19,563.20
18,934.00
26,270.00
41,331.00
33,861.00
Total Equity
19,563.20
18,934.00
26,270.00
41,331.00
33,861.00
Liabilities & Shareholders' Equity
33,769.10
25,375.00
30,874.00
47,010.00
38,561.00

About aXichem AB

View Profile
Address
Vestre Torggaten 1
Bergen HL 5015
Norway
Employees -
Website http://www.axichem.se
Updated 09/14/2018
aXichem AB develops and sells natural-analogue industrial compounds. It offers bio-repellents, feed ingredients, and food and dietary supplements through its product, aXiphen an antifouling agent and analogue of natural capsaicin. The company was founded by Torsten Helsing in 1999 and is headquartered in Bergen, Norway.